Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Boehringer Ingelheim
Boehringer Ingelheim
Citing toxicity concerns, Boehringer Ingelheim drops short-lived IPF pact — keeping $1B+ in its pocket
Endpoints
Wed, 11/11/20 - 11:07 am
Boehringer Ingelheim
IPF
Bridge Biotherapeutics
BBT-877
Boehringer, Yale trial digital tech in heart failure
Pharmaforum
Fri, 10/16/20 - 11:08 am
Boehringer Ingelheim
Yale
digital therapeutics
digital health
heart failure
Boehringer hopes schizophrenia apps will Click into place
EP Vantage
Tue, 09/15/20 - 10:49 am
digital therapeutics
Boehringer Ingelheim
Click Therapeutics
schizophrenia
CT-155
After Novartis left, Boehringer bets up to $500M on the field of prescription smartphone app
Endpoints
Fri, 09/11/20 - 10:44 am
Boehringer Ingelheim
digital therapeutics
Click Therapeutics
mobile apps
Novartis
ESC 2020 – Jardiance joins Farxiga in showing heart failure benefit
EP Vantage
Mon, 08/31/20 - 10:13 am
ESC
Eli Lilly
Boehringer Ingelheim
Farxiga
Jardiance
heart failure
AstraZeneca
Boehringer calls off €627M deal with GSK spinout, passing on schizophrenia drug option
Endpoints
Wed, 08/26/20 - 11:09 am
Boehringer Ingelheim
GSK
schizophrenia
Autifony
AUT00206
Boehringer Ingelheim to Pay $379,000 to Settle Wage Discrimination Charges
BioSpace
Fri, 08/21/20 - 11:38 pm
Boehringer Ingelheim
gender discrimination
Boehringer and Lilly’s Jardiance Hits Mark in Decreasing Risk of Death in Heart Failure
BioSpace
Fri, 07/31/20 - 10:40 am
Boehringer Ingelheim
Eli Lilly
Jardiance
heart failure
diabetes
clinical trials
Boehringer Ingelheim beefs up vet portfolio with GST buyout
Endpoints
Mon, 07/27/20 - 11:10 am
animal health
Boehringer Ingelheim
M&A
Global Stem Technology
Boehringer Ingelheim-backed COVID researchers identify new antibodies to fight the virus
Fierce Pharma
Fri, 07/10/20 - 10:58 am
Boehringer Ingelheim
COVID-19
antivirals
antibodies
Boehringer creates Shanghai hub to connect with Chinese R&D groups
Fierce Biotech
Mon, 07/6/20 - 10:30 am
Boehringer Ingelheim
China
Shanghai
R&D
Looking for 'external innovation,' Boehringer Ingelheim reserves $500M+ for new Shanghai hub
Endpoints
Thu, 07/2/20 - 11:03 am
China
Shanghai
Boehringer Ingelheim
drug manufacturing
Coalition of drugmakers to unveil $1B venture to pursue antibiotics
Beckers Hospital Review
Mon, 06/29/20 - 10:01 am
Big Pharma
drug development
antibiotics
innovation
Eli Lilly
Pfizer
Merck
Boehringer Ingelheim
Bayer
CARB-X
Boehringer debuts IPF songwriting contest with MLB player-turned-singer Bernie Williams
Fierce Pharma
Mon, 06/29/20 - 09:58 am
Boehringer Ingelheim
IPF
drug marketing
Boehringer Ingelheim nabs new US president and CEO
Endpoints
Fri, 06/19/20 - 11:12 am
Boehringer Ingelheim
Pharma CEOs
Jean-Michel Boers
Boehringer launches open innovation project for work-at-home scientists
Pharmaforum
Thu, 06/11/20 - 11:12 am
Boehringer Ingelheim
R&D
pandemic
COVID-19
opnMe
Boehringer Ingelheim collaborates with CDR-Life to develop antibody fragment-based therapeutics for geographic atrophy
Pharmaceutical Business Review
Thu, 05/14/20 - 11:59 am
Boehringer Ingelheim
CDR-Life
antibody fragments
geographic atrophy
R&D
Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Pipeline
Xconomy
Thu, 05/14/20 - 10:22 am
Northern Biologics
Boehringer Ingelheim
cancer immunology
Boehringer Ingelheim adds second AI partner in a month
Endpoints
Wed, 05/6/20 - 12:14 pm
Boehringer Ingelheim
artificial intelligence
BERG
Bayesian AI
biomarkers
Crohn's Disease
inflammatory bowel disease
The top pharma companies in social media
Fierce Pharma
Mon, 05/4/20 - 11:02 am
social media
Boehringer Ingelheim
AbbVie
GSK
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »